Related Experiment Videos
Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression
Y M Huang1, M Kouwenhoven, Y P Jin
1Neuroimmunology Unit, Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 27, 2001
Summary
Dendritic cells (DC) show altered surface molecules in multiple sclerosis (MS). Specifically, higher CD1a+ DC and lower CD86+ DC proportions were observed in MS patients, suggesting a role for these antigen-presenting cells in the disease.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells (APCs) orchestrating immune responses.
- The role of DCs in multiple sclerosis (MS), an autoimmune CNS disease, remains largely unexplored.
- Auto-aggressive T cells targeting myelin antigens are implicated in MS pathogenesis.
Purpose of the Study:
- To compare the phenotype and cytokine secretion of DCs from MS patients, other neurological disease (OND) patients, and healthy subjects.
- To investigate the potential involvement of DCs in the immune dysregulation observed in MS.
Main Methods:
- Dendritic cells (DCs) were generated from blood adherent mononuclear cells (MNCs) using GM-CSF and IL-4 for 7 days.
- Phenotypic analysis of DCs included assessing CD1a and CD11c expression.
- Cytokine production (IL-10, IL-12 p40) and co-stimulatory molecule expression (CD86) were evaluated.
Main Results:
- DC yield and morphology were comparable between MS patients and controls.
- A higher proportion of CD1a+ DCs was found in MS patients compared to controls.
- Lower proportions of CD86+ DCs were observed in untreated MS patients, but not in IFN-beta treated patients.
- IL-10 and IL-12 p40 production did not differ significantly between groups.
Conclusions:
- Alterations in functionally important surface molecules on dendritic cells (DCs) are associated with multiple sclerosis (MS).
- The increased CD1a+ DC proportion and decreased CD86+ DC proportion in MS patients suggest a specific DC phenotype in this disease.
- These findings highlight DCs as potential players in MS pathogenesis and warrant further investigation into their immunomodulatory functions.